Global Underuse of Cardiovascular Disease Medications Calls for Enhanced Strategies

A recent study published in the Journal of the American College of Cardiology (JACC) reveals a concerning global underutilization of secondary prevention medications for cardiovascular diseases (CVD). The research, which monitored participants from 17 countries over a span of 12 years, indicates that the use of these essential medications remains critically low with negligible signs of improvement.

The findings underscore an urgent need for additional strategies to bolster the usage of CVD medications. This is crucial not only for enhancing the management of cardiovascular diseases but also for reducing premature mortality rates associated with these conditions.

The study’s results highlight a significant gap in global healthcare practices concerning cardiovascular disease management and point towards an immediate requirement for international health bodies to address this issue comprehensively.

Published: February 4, 2025

Newsflash | Powered by GeneOnline AI

Author

Mark Chiang

Related Post

Healthcare Expo 2025

From Silicon Valley to South Africa: The Race to Harmonize the World’s Medical Markets

2025-12-09

Ranking & Reports

Hong Kong’s Global Health Playbook: Patrick Lau on Biotech, Medtech, and Collaborative Innovation

2025-05-27

R&D Frontiers

ASGH 2025 Tackles Global Healthcare’s Core Challenges: Equity and Sustainability

2025-05-26